Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2005
08/11/2005US20050176704 Hydroxymorpholinone derivative and medicinal use thereof
08/11/2005US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors
08/11/2005US20050176698 Neuropeptide Y antagonists
08/11/2005US20050176691 Combination therapy for the treatment of estrogen-sensitive disease
08/11/2005US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases
08/11/2005US20050176685 Administering bisphosphonate compounds such as ibandronate, minodronate, pamidronate, risedronate, zoledronate, and alendronate; osteoporosis
08/11/2005US20050176684 5-(4-Bromo-3-aminophenyl)-2-furanphosphonic acid; fructose-1,6-biphosphatase inhibitor; diabetes type 1 and 2, glycogen storage diseases, cardiovascular diseases with increased insulin levels, atherosclerosis; in vitro, in vivo;
08/11/2005US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections
08/11/2005US20050176672 Use of cationic lipids to generate anti-tumor immunity
08/11/2005US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/11/2005US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity
08/11/2005US20050176632 Angiogenesis inhibitors
08/11/2005US20050176631 Method for reducing morbidity and mortality in critically ill patients
08/11/2005US20050176630 Modification of feeding behavior
08/11/2005US20050176143 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/11/2005US20050176137 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/11/2005US20050176123 Protease inhibitor
08/11/2005US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor
08/11/2005US20050176060 Crystal structure
08/11/2005US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics
08/11/2005US20050175998 Immunoconjugate for stimulating myelinogenesis, differentiation of oligodendroglial precursor cells, tyrosine kinase, the expression of myelin basic protein and detecting myelinogenetic oligodendroglias
08/11/2005US20050175724 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic
08/11/2005US20050175691 Pramipexole once-daily dosage form
08/11/2005US20050175643 Fermentation microbe and metabolites, thickener, water, and carbon dioxide; adding water and thickener to carbon dioxide-impermeable sealable container; low speed depressurization to degas raw materials; filling with carbon dioxide; skin and atopic disorders; wound healing agents; dermatitis, pruritus
08/11/2005US20050175624 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides
08/11/2005US20050175609 Placental growth factor as a target for the treatment of osteoporosis
08/11/2005US20050175580 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
08/11/2005US20050175539 Compositions inhibiting rejection in organ transplantation and method of using the same
08/11/2005CA2555763A1 Therapeutic agent for vasospasm accompanying bypass operation
08/11/2005CA2554749A1 P2x receptor inhibitor
08/10/2005EP1561820A1 Novel substance fki-1033 and process for producing the same
08/10/2005EP1561817A2 Modified CEA and uses thereof
08/10/2005EP1561815A2 Tissue-specific and target rna-specific ribozymes
08/10/2005EP1561759A1 Cell death-inducing agent
08/10/2005EP1561757A1 Modified factor VIII
08/10/2005EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
08/10/2005EP1561749A1 TNF-Alpha production inhibitors for the treatment of autoimmune diseases
08/10/2005EP1561471A1 Cell growth regulator
08/10/2005EP1561464A2 Use of cyclopamine in the treatment of basal cell carcinoma and other tumors
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560816A1 Quinazoline derivatives
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1507514A4 Controlled release compositions of estradiol metabolites
08/10/2005EP1471919B1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005EP1395599B1 Anti-tumour anthracycline glycoside 14-sulfonic acid derivatives
08/10/2005EP1395265A4 Combretastatin a-3 prodrug
08/10/2005EP1392674B1 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors
08/10/2005EP1368340B1 Piperazine derivatives as melanocortin receptor agonists
08/10/2005EP1358187B1 Naphthyridine derivatives
08/10/2005EP1358168B1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
08/10/2005EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors
08/10/2005EP1339679B1 3-arylindole derivatives and their use as cb2 receptor agonists
08/10/2005EP1324760A4 Creatine ester pronutrient compounds and formulations
08/10/2005EP1292697A4 Method for preparing a physiologically active il-18 polypeptide
08/10/2005EP1292581B1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists
08/10/2005EP1208103B1 Reverse-turn mimetics and methods relating thereto
08/10/2005EP1194425B1 Substituted benzimidazole
08/10/2005EP1098891B1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments
08/10/2005EP1096941B1 Bone marrow cells as a source of neurons for brain and spinal cord repair
08/10/2005EP1086093B1 Tetrahydroquinoline derivatives as glycine antagonists
08/10/2005EP0837883B1 Method of solubilizing, purifying, and refolding protein
08/10/2005EP0833622B1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
08/10/2005EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
08/10/2005CN1653454A Method of forming molecule function network
08/10/2005CN1653073A Substituted phenylacetic acids
08/10/2005CN1653070A Heterocyclic amide derivatives as inhibitors of glycogen phoshorylase
08/10/2005CN1653068A Novel diazabicyclic biaryl derivatives
08/10/2005CN1653067A Carbazole derivatives and their use as NPY5 receptor antagonists
08/10/2005CN1653066A Non-nucleoside reverse transcriptase inhibitors
08/10/2005CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them
08/10/2005CN1653063A (S)-4-amino-5-chloro-2-methoxy-N-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, and method for producing the same, pharmaceutical composition containing the same and i
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1653055A Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same
08/10/2005CN1653054A Benzoxazine derivatives as 5-HT6 modulators and uses thereof
08/10/2005CN1653053A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
08/10/2005CN1653052A Novel imidazole compounds, method for preparing same and use thereof as medicines
08/10/2005CN1653046A 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
08/10/2005CN1653044A Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
08/10/2005CN1653040A HIF hydroxylase inhibitors
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653032A Substituted phenylalkanoic acid derivatives and use thereof
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1652844A Combination of a CDK inhibitor and 5-FU for the treatment of cancer
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1652842A 3'- (2z)- 1-(3, 4-dimethylphenyl)-1, 5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1, 1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652820A Methods of treatment using CTLA-4 antibodies
08/10/2005CN1652814A Induction of antigen specific immunologic tolerance
08/10/2005CN1652812A Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes
08/10/2005CN1652810A Immunosuppressant compounds, methods and uses related thereto
08/10/2005CN1652805A An herbal composition for the treatment and remedy of bronchial respiratory difficulties
08/10/2005CN1652803A Medicine for prevention of and treatment for amyloidosis
08/10/2005CN1652799A Sulfatase inhibiting progestogen-only contraceptive regimens
08/10/2005CN1652798A Continuous sulfatase inhibiting progestogen hormone replacement therapy
08/10/2005CN1652796A Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
08/10/2005CN1652790A Novel crystalline forms of the anti-cancer compound ZD1839
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 1564